381 related articles for article (PubMed ID: 17765654)
1. Percutaneous devices for stroke prevention.
Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
3. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
[TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
Syed TM; Halperin JL
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
[TBL] [Abstract][Full Text] [Related]
5. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
Chiam PT; Ruiz CE
J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
[TBL] [Abstract][Full Text] [Related]
8. Prevention of stroke by percutaneous left atrial appendage closure: short term follow-up.
De Meester P; Thijs V; Van Deyk K; Budts W
Int J Cardiol; 2010 Jul; 142(2):195-6. PubMed ID: 19095320
[TBL] [Abstract][Full Text] [Related]
9. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention.
Crystal E; Lamy A; Connolly SJ; Kleine P; Hohnloser SH; Semelhago L; Abouzhar L; Cybulsky I; Shragge B; Teoh K; Lonn E; Sawchuk C; Oezaslan F;
Am Heart J; 2003 Jan; 145(1):174-8. PubMed ID: 12514671
[TBL] [Abstract][Full Text] [Related]
10. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
Landmesser U; Holmes DR
Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
[TBL] [Abstract][Full Text] [Related]
11. Patent foramen ovale and left atrial appendage: new devices and methods for closure.
Hein R; Bayard Y; Taaffe M; Büscheck F; Ostermayer S; Billinger K; Reschke M; Trepels T; Lissmann-Jensen H; Lang K; Römer A; Wilson N; Sievert H
Pediatr Cardiol; 2005; 26(3):234-40. PubMed ID: 16132300
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation.
Gibson DN; Price MJ; Ahern TS; Teirstein PS
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834
[No Abstract] [Full Text] [Related]
13. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
Grosset-Janin D; Barth E; Bertrand B; Detante O
Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
[TBL] [Abstract][Full Text] [Related]
15. Nonpharmacologic approaches to stroke prevention in atrial fibrillation.
Whitlock RP; Hanif H; Danter M
Can J Cardiol; 2013 Jul; 29(7 Suppl):S79-86. PubMed ID: 23790602
[TBL] [Abstract][Full Text] [Related]
16. Stroke prevention in atrial fibrillation.
Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transcatheter closure of patent foramen ovale.
Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA
Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740
[TBL] [Abstract][Full Text] [Related]
18. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
[TBL] [Abstract][Full Text] [Related]
19. Nonpharmacologic stroke prevention in atrial fibrillation.
Onalan O; Lashevsky I; Hamad A; Crystal E
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent foramen ovale in older adults.
Kiblawi FM; Sommer RJ; Levchuck SG
Catheter Cardiovasc Interv; 2006 Jul; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
